Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).

Molecular genetics and metabolism - 1 Oct 1999

Matthijs G, Schollen E, Heykants L, Grünewald S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Congenital Disorders of Glycosylation
Share to Mutation
Share to Phosphotransferases (Phosphomutases)

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10527672
DOI: 10.1006/mgme.1999.2914

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).PMID 10527672Read ↗

The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)Semantic proximity Read ↗

Clinical utility gene card for: Phosphomannomutase 2 deficiency.Semantic proximity Read ↗

A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG.Semantic proximity Read ↗

Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).Semantic proximity Read ↗

Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).Semantic proximity Read ↗

A deletion-insertion mutation in the phosphomannomutase 2 gene in an African American patient with congenital disorders of glycosylation-Ia.Semantic proximity Read ↗

Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures.Semantic proximity Read ↗

The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers.Semantic proximity Read ↗

Clinical utility gene card for: Phosphomannose isomerase deficiency.Semantic proximity Read ↗

Expanding the phenotype of phosphomannomutase-2 gene congenital disorder of glycosylation: Cervical dystonia.Semantic proximity Read ↗

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.Semantic proximity Read ↗

Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.